Our analysis of CCND1 mutations subsequently focused on two endometrial adenocarcinoma cohorts, since this cancer subtype was most frequently enriched for c-terminal cyclin D1 mutations (Fig 1C and 1D). This evidence concerns the gene CCND1 and cancer.